Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Associated Inferior Vena Cava Tumor Thrombus (NEOPAX)

Conditions:   Renal Cancer;   Kidney Cancer;   Renal Cell Carcinoma;   Inferior Vena Cava Thrombosis Interventions:   Drug: Axitinib;   Drug: Pembrolizumab Sponsors:   University of Colorado, Denver;   Cancer League of Colorado Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials